Toe nail fungus Arpida Adds a Late Stage Antifungal to its Pipeline Through Acqusition of TLT Medical Ltd. (PR Newswire via Yahoo! Finance)

Arpida Ltd. today announced the acquisition of TLT Medical Ltd., a Swiss privately-owned biopharmaceutical company with an innovative onychomycosis therapy. European regulatory authorities have granted authorisation to initiate a pivotal Phase III clinical trial that aims to demonstrate superiority of the TLT therapy compared to the standard of care topical treatment for mild to moderate OM.